(Q38945878)

7 September 2017

Sex difference in liver-related mortality and transplantation associated with dietary cholesterol in chronic hepatitis C virus infection (English)

1 reference

7 September 2017

1 reference

1 reference

Lei Yu

1

1 reference

PubMed ID

26541123

7 September 2017

Chihiro Morishima

series ordinal

2

1 reference

PubMed ID

26541123

7 September 2017

George N Ioannou

series ordinal

3

1 reference

7 September 2017

6 November 2015

1 reference

British Journal of Nutrition

7 September 2017

1 reference

7 September 2017

115

1 reference

7 September 2017

2

1 reference

7 September 2017

193-201

1 reference

Multiple functions of microsomal triglyceride transfer protein

7 September 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Consequences of cellular cholesterol accumulation: basic concepts and physiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Smoking and age at menopause in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Hepatitis C in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Energy adjustment methods for nutritional epidemiology: the effect of categorization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Dietary cholesterol intake is associated with progression of liver disease in patients with chronic hepatitis C: analysis of the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Microsomal triglyceride transfer protein enhances cellular cholesteryl esterification by relieving product inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 1. Morphology and inhibition of fibrogenesis by dipyridamole

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

7 January 2021

Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

7 January 2021

45-year follow-up of hepatitis C virus infection in healthy young adults

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

7 January 2021

Psychosocial predictors of energy underreporting in a large doubly labeled water study.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

7 January 2021

Adjustment for total energy intake in epidemiologic studies

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

7 January 2021

Sticker shock and the price of new therapies for hepatitis C: is it worth it?

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

7 January 2021

Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004158

7 January 2021

10.1017/S0007114515004158

Identifiers

DOI

1 reference

7 September 2017

1 reference

PubMed ID

26541123